{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T22:24:44Z","timestamp":1792448684980,"version":"4.5.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,8,6]],"date-time":"2015-08-06T00:00:00Z","timestamp":1438819200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunobiology"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.imbio.2015.08.001","type":"journal-article","created":{"date-parts":[[2015,8,10]],"date-time":"2015-08-10T13:33:20Z","timestamp":1439213600000},"page":"701-708","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Inhibition of the alternative complement pathway by antisense oligonucleotides targeting complement factor B improves lupus nephritis in mice"],"prefix":"10.1016","volume":"221","author":[{"given":"Tamar R.","family":"Grossman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa A.","family":"Hettrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert B.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gene","family":"Hung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raechel","family":"Peralta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Watt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott P.","family":"Henry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Adamson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brett P.","family":"Monia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael L.","family":"McCaleb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.imbio.2015.08.001_bib0005","doi-asserted-by":"crossref","first-page":"11994","DOI":"10.1074\/jbc.272.18.11994","article-title":"2\u2032-O-(2-Methoxy) ethyl-modified anti-intercellular adhesion molecule 1 (ICAM-1) oligonucleotides selectively increase the ICAM-1 mRNA level and inhibit formation of the ICAM-1 translation initiation complex in human umbilical vein endothelial cells","volume":"272","author":"Baker","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.imbio.2015.08.001_bib0010","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.semnephrol.2006.09.009","article-title":"Complement in lupus nephritis: the good, the bad, and the unknown","volume":"27","author":"Bao","year":"2007","journal-title":"Semin Nephrol."},{"key":"10.1016\/j.imbio.2015.08.001_bib0015","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1146\/annurev.pharmtox.010909.105654","article-title":"RNA targeting therapeutics: molecular mechanisms of antisense oligonucleotides as a therapeutic platform","volume":"50","author":"Bennett","year":"2010","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.imbio.2015.08.001_bib0020","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1084\/jem.154.6.1779","article-title":"Renal localization of the membrane attack complex in systemic lupus erythematosus nephritis","volume":"154","author":"Biesecker","year":"1981","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.imbio.2015.08.001_bib0025","doi-asserted-by":"crossref","first-page":"2774","DOI":"10.1016\/j.molimm.2009.04.029","article-title":"Complement in human diseases: lessons from complement deficiencies","volume":"46","author":"Botto","year":"2009","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.imbio.2015.08.001_bib0030","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1136\/bmj.3.5882.668","article-title":"Plasma C and C4 concentrations in management of glomerulonephritis","volume":"3","author":"Cameron","year":"1973","journal-title":"Br. Med. J."},{"key":"10.1016\/j.imbio.2015.08.001_bib0035","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1038\/nri1456","article-title":"A protective role for innate immunity in systemic lupus erythematosus","volume":"4","author":"Carroll","year":"2004","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.imbio.2015.08.001_bib0040","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1126\/science.279.5353.1052","article-title":"Uncoupling of immune complex formation and kidney damage in autoimmune glomerulonephritis","volume":"279","author":"Clynes","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.imbio.2015.08.001_bib0045","series-title":"Antisense Drug Technology: Principles, Strategies, and Applications","first-page":"273","author":"Crooke","year":"2008"},{"key":"10.1016\/j.imbio.2015.08.001_bib0050","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1600-065X.1995.tb00065.x","article-title":"Genetic contributions to lupus-like disease in (NZB\u00d7NZW)F1 mice","volume":"144","author":"Drake","year":"1995","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.imbio.2015.08.001_bib0055","doi-asserted-by":"crossref","first-page":"125","DOI":"10.2165\/11208420-000000000-00000","article-title":"Eculizumab: a guide to its use in paroxysmal nocturnal hemoglobinuria","volume":"26","author":"Keating","year":"2012","journal-title":"BioDrugs"},{"issue":"5\u20136","key":"10.1016\/j.imbio.2015.08.001_bib0060","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1159\/000463194","article-title":"Changes in plasma complement C4 and factor B allotypes after liver transplantation","volume":"8","author":"Koskimies","year":"1991","journal-title":"Complement Inflamm."},{"key":"10.1016\/j.imbio.2015.08.001_bib0065","first-page":"153","article-title":"An attempt to characterize the lupus erythematosus cell antigen","volume":"4","author":"Lachmann","year":"1961","journal-title":"Immunology"},{"key":"10.1016\/j.imbio.2015.08.001_bib0070","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0065-2776(08)04004-2","article-title":"The amplification loop of the complement pathways","volume":"104","author":"Lachmann","year":"2009","journal-title":"Adv. Immunol."},{"key":"10.1016\/j.imbio.2015.08.001_bib0075","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s40256-014-0077-0","article-title":"Mipomersen is a promising therapy in the management of hypercholesterolemia: a meta-analysis of randomized controlled trials","volume":"14","author":"Li","year":"2014","journal-title":"Am. J. Cardiovasc. Drugs"},{"key":"10.1016\/j.imbio.2015.08.001_bib0080","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1001\/archinte.161.1.25","article-title":"The diagnosis of glomerular diseases acute glomerulonephritis and the nephrotic syndrome","volume":"161","author":"Madaio","year":"2001","journal-title":"Arch. Intern. Med."},{"issue":"Suppl. 1","key":"10.1016\/j.imbio.2015.08.001_bib0085","first-page":"S41","article-title":"Local tissue complement synthesis\u2014fine tuning a blunt instrument","volume":"49","author":"Marsh","year":"2001","journal-title":"Arch. Immol. Ther. Exp. (Warsz)"},{"key":"10.1016\/j.imbio.2015.08.001_bib0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1365-2249.1997.d01-890.x","article-title":"Extrahepatic complement biosynthesis: where, when and why?","volume":"107","author":"Morgan","year":"1997","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.imbio.2015.08.001_bib0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0065-2776(08)60042-5","article-title":"Molecular biology and chemistry of the alternative pathway of complement","volume":"29","author":"Muller-Eberhard","year":"1980","journal-title":"Adv. Immunol."},{"key":"10.1016\/j.imbio.2015.08.001_bib0100","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1172\/JCI108065","article-title":"Complement breakdown products in plasma from patients with systemic lupus erythematosus and patients with membranoproliferative or other glomerulonephritis","volume":"56","author":"Perrin","year":"1975","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.imbio.2015.08.001_bib0105","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1046\/j.1523-1755.1998.00723.x","article-title":"Immune complex glomerulonephritis in C4- and C3-deficient mice","volume":"53","author":"Quigg","year":"1998","journal-title":"Kidney Int."},{"key":"10.1016\/j.imbio.2015.08.001_bib0110","first-page":"151","article-title":"Preparation of isolated rat liver hepatocytes","volume":"5","author":"Quistorff","year":"1990","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.imbio.2015.08.001_bib0115","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1038\/nbt1342","article-title":"Complement-targeted therapeutics","volume":"25","author":"Ricklin","year":"2007","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.imbio.2015.08.001_bib0120","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1084\/jem.168.5.1917","article-title":"Interferon gamma induces synthesis of complement alternative pathway proteins by human endothelial cells in culture","volume":"168","author":"Ripoche","year":"1988","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.imbio.2015.08.001_bib0125","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1053\/j.ajkd.2013.11.023","article-title":"Lupus nephritis: the evolving role of novel therapeutics","volume":"63","author":"Rovin","year":"2014","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.imbio.2015.08.001_bib0130","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0162-3109(00)80299-4","article-title":"Complement inhibitors: a resurgent concept in anti-inflammatory therapeutics","volume":"49","author":"Sahu","year":"2000","journal-title":"Immunopharmacology"},{"key":"10.1016\/j.imbio.2015.08.001_bib0135","doi-asserted-by":"crossref","first-page":"3948","DOI":"10.1073\/pnas.75.8.3948","article-title":"Initiation of the alternative pathway of complement: recognition of activators by bound C3b and assembly of the entire pathway from six isolated proteins","volume":"75","author":"Schreiber","year":"1978","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.imbio.2015.08.001_bib0140","doi-asserted-by":"crossref","first-page":"6444","DOI":"10.4049\/jimmunol.166.10.6444","article-title":"Complement component C3 is not required for full expression of immune complex glomerulonephritis in MRL\/lpr mice","volume":"166","author":"Sekine","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.imbio.2015.08.001_bib0145","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1056\/NEJMc1306326","article-title":"Deficiency in complement factor B","volume":"369","author":"Slade","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.imbio.2015.08.001_bib0150","article-title":"The Pathogenesis of lupus nephritis","volume":"5","author":"Sterner","year":"2014","journal-title":"J. Clin. Cell Immunol."},{"key":"10.1016\/j.imbio.2015.08.001_bib0155","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1172\/JCI113472","article-title":"Pulmonary alveolar type II epithelial cells synthesize and secrete proteins of the classical and alternative complement pathways","volume":"81","author":"Strunk","year":"1988","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.imbio.2015.08.001_bib0160","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0065-2776(08)60342-9","article-title":"Murine models of systemic lupus erythematosus","volume":"37","author":"Theofilopoulos","year":"1985","journal-title":"Adv. Immunol."},{"issue":"Suppl 3","key":"10.1016\/j.imbio.2015.08.001_bib0165","doi-asserted-by":"crossref","first-page":"S279","DOI":"10.1186\/ar586","article-title":"Complement and systemic lupus erythematosus","volume":"4","author":"Walport","year":"2002","journal-title":"Arthritis Res."},{"key":"10.1016\/j.imbio.2015.08.001_bib0170","doi-asserted-by":"crossref","first-page":"8563","DOI":"10.1073\/pnas.93.16.8563","article-title":"Amelioration of lupus-like autoimmune disease in NZB\/WF1 mice after treatment with a blocking monoclonal antibody specific for complement component C5","volume":"93","author":"Wang","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.imbio.2015.08.001_bib0175","doi-asserted-by":"crossref","first-page":"786","DOI":"10.4049\/jimmunol.164.2.786","article-title":"Modulation of renal disease in MRL\/lpr mice genetically deficient in the alternative complement pathway factor B","volume":"164","author":"Watanabe","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.imbio.2015.08.001_bib0180","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1084\/jem.176.6.1645","article-title":"Genetic analysis of MRL-lpr mice: relationship of the Fas apoptosis gene to disease manifestations and renal disease-modifying loci","volume":"176","author":"Watson","year":"1992","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.imbio.2015.08.001_bib0185","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1084\/jem.151.3.501","article-title":"Biosynthesis of the complement components and the regulatory proteins of the alternative complement pathway by human peripheral blood monocytes","volume":"151","author":"Whaley","year":"1980","journal-title":"J. Exp. Med."}],"container-title":["Immunobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0171298515300413?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0171298515300413?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T16:40:23Z","timestamp":1759250423000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0171298515300413"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":37,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["S0171298515300413"],"URL":"https:\/\/doi.org\/10.1016\/j.imbio.2015.08.001","relation":{},"ISSN":["0171-2985"],"issn-type":[{"value":"0171-2985","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of the alternative complement pathway by antisense oligonucleotides targeting complement factor B improves lupus nephritis in mice","name":"articletitle","label":"Article Title"},{"value":"Immunobiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imbio.2015.08.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2015 The Authors. Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}]}}